Kiora Short Term Debt from 2010 to 2025

KPRX Stock  USD 3.37  0.02  0.60%   
Kiora Pharmaceuticals Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt will likely drop to about 40.2 K in 2025. During the period from 2010 to 2025, Kiora Pharmaceuticals Short Term Debt regression line of annual values had r-squared of  0.08 and arithmetic mean of  393,750. View All Fundamentals
 
Short Term Debt  
First Reported
2013-12-31
Previous Quarter
84.3 K
Current Value
33.4 K
Quarterly Volatility
882.5 K
 
Yuan Drop
 
Covid
Check Kiora Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiora Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 84.2 K, Selling General Administrative of 4.8 M or Other Operating Expenses of 10.3 M, as well as many indicators such as Price To Sales Ratio of 16 K, Dividend Yield of 0.0 or PTB Ratio of 0.39. Kiora financial statements analysis is a perfect complement when working with Kiora Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Kiora Pharmaceuticals Correlation against competitors.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.

Latest Kiora Pharmaceuticals' Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of Kiora Pharmaceuticals over the last few years. It is Kiora Pharmaceuticals' Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kiora Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Pretty Stable
   Short Term Debt   
83.9260.237.211.47.142.440.2210%-9%-11%-78%-10%-5%100%
       Timeline  

Kiora Short Term Debt Regression Statistics

Arithmetic Mean393,750
Geometric Mean67,682
Coefficient Of Variation228.01
Mean Deviation555,656
Median42,362
Standard Deviation897,780
Sample Variance806B
Range3.2M
R-Value(0.28)
Mean Square Error798B
R-Squared0.08
Significance0.30
Slope(51,956)
Total Sum of Squares12.1T

Kiora Short Term Debt History

202540.2 K
202442.4 K
202347.1 K
2022211.6 K
2021237.7 K
2020260.6 K
201983.9 K

About Kiora Pharmaceuticals Financial Statements

Kiora Pharmaceuticals investors use historical fundamental indicators, such as Kiora Pharmaceuticals' Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kiora Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt42.4 K40.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Kiora Stock Analysis

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…